SPRY: ARS Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 780.70
Enterprise Value ($M) 709.73
Book Value ($M) 230.76
Book Value / Share 2.39
Price / Book 3.38
NCAV ($M) 229.30
NCAV / Share 2.38
Price / NCAV 3.40

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.20
Return on Equity (ROE) -0.21

Liquidity (mrq)
Quick Ratio 96.92
Current Ratio 96.92

Balance Sheet (mrq) ($M)
Current Assets 231.73
Assets 233.19
Liabilities 2.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.03
Operating Income -67.52
Net Income -54.37

Cash Flow Statement (mra) ($M)
Cash From Operations -59.27
Cash from Investing -87.18
Cash from Financing 6.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-29 13D/A Ra Capital Management, L.p. 11.30 14.81
02-09 13G/A Fmr Llc 1.25 -77.61
09-01 13D/A Bell Robert G. 4.50 -49.63

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 118,354 520,298 22.75
2024-04-25 93,452 196,262 47.62
2024-04-24 52,484 156,334 33.57
2024-04-23 116,015 209,455 55.39

(click for more detail)

Similar Companies
SLGL – Sol-Gel Technologies Ltd. SMMT – Summit Therapeutics Inc.
SNSE – Sensei Biotherapeutics, Inc. STRO – Sutro Biopharma, Inc.
SUPN – Supernus Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io